Lilly, Novo Nordisk and Vertex lead on market capitalisation growth
Drug Discovery World
FEBRUARY 22, 2024
trillion in 2023, according to data analysts GlobalData. The top 20 global biopharmaceutical companies experienced varied year-on-year (YoY) market capitalisation shifts in 2023 amid the macroeconomic headwinds, steep patent cliffs and the commencement of US drug price negotiations under the Inflation Reduction Act (IRA).
Let's personalize your content